middl
east
respiratori
syndrom
coronaviru
merscov
emerg
zoonot
viru
consid
one
major
public
threat
total
number
laboratoryconfirm
case
associ
death
report
world
health
organ
januari
transmiss
viru
expect
camel
found
middl
eastern
countri
via
anim
human
interact
genom
structur
provid
inform
pathogen
associ
virul
factor
present
viru
recent
studi
suggest
limit
insight
avail
develop
novel
therapeut
strategi
induc
immun
viru
sever
merscov
infect
highlight
necess
effect
approach
develop
variou
therapeut
remedi
thu
present
review
comprehens
critic
illustr
recent
aspect
epidemiolog
viru
structur
function
featur
viral
genom
viral
entri
transmiss
major
mechan
pathogenesi
associ
virul
factor
current
anim
model
detect
method
novel
strategi
develop
vaccin
merscov
review
illustr
molecular
comput
virtual
screen
platform
provid
insight
identif
put
drug
target
novel
lead
molecul
toward
develop
therapeut
remedi
coronavirus
circul
human
popul
caus
mild
respiratori
infect
hamr
procknow
fouchier
et
al
van
der
hoek
et
al
woo
et
al
last
two
decad
two
zoonot
emerg
coronavirus
human
popul
link
sever
acut
respiratori
syndrom
coronaviru
sarscov
drosten
et
al
kuiken
et
al
middl
east
respiratori
syndrom
coronaviru
merscov
chafekar
field
middl
east
respiratori
syndrom
coronaviru
belong
cladec
de
groot
et
al
initi
known
human
coronaviru
erasmu
medic
chan
et
al
merscov
infect
result
high
mortal
rate
human
till
date
limit
therapeut
intervent
vaccin
avail
treatment
infect
caus
viru
mustafa
et
al
hui
et
al
middl
east
respiratori
syndrom
coronaviru
found
variou
natur
host
dromedari
calv
camelu
dromedariu
bat
vespertilio
superan
neoromicia
capensi
european
hedgehog
erinaceu
europaeu
zhang
et
al
lau
et
al
replic
viru
observ
variou
anim
rabbit
goat
civet
pig
camelid
hors
muller
et
al
chan
et
al
altawfiq
et
al
eckerl
et
al
meyer
et
al
preval
merscov
recent
report
noncamelid
domest
mammal
sheep
goat
donkey
cow
contact
camel
kandeil
et
al
origin
human
merscov
consid
bat
sever
coronavirus
isol
found
genet
similar
human
merscov
phylogenet
analysi
merscov
show
close
relationship
pipistrellu
bat
coronaviru
tylonycteri
bat
coronaviru
seling
et
al
studi
suggest
evid
viru
show
camel
origin
zhang
et
al
studi
reveal
seropreval
viru
greater
among
peopl
exhibit
direct
indirect
contact
dromedari
camel
compar
exhibit
gener
popul
watson
et
al
zhou
et
al
conzad
et
al
recent
studi
reveal
preval
merscov
infect
camel
worker
found
high
saudi
arabia
alshukairi
et
al
thu
review
provid
recent
perspect
epidemiolog
genom
composit
merscov
special
emphasi
viral
entri
clinic
manifest
mechan
pathogenesi
anim
model
detect
develop
vaccin
insight
variou
comput
biolog
perspect
first
case
merscov
infect
report
saudi
arabia
period
emerg
viru
infect
propag
across
countri
contribut
wide
number
laboratoryconfirm
case
merscov
outbreak
south
korea
involv
case
includ
fatal
total
case
transmiss
due
five
super
spreader
case
patient
experienc
nosocomi
transmiss
hospit
epidem
last
month
govern
author
quarantin
person
day
manag
outbreak
outbreak
provid
exclus
opportun
seal
gap
awar
merscov
infect
recent
statist
suggest
decemb
total
laboratoryconfirm
case
merscov
associ
death
case
fatal
rate
report
countri
harcourt
et
al
world
health
organ
among
variou
case
confirm
case
relat
death
fatal
rate
report
saudi
arabia
harcourt
et
al
world
health
organ
comprehens
report
laboratori
case
confirm
report
kingdom
saudi
arabia
earli
year
coronavirus
acquir
great
import
research
develop
emerg
sar
year
mer
interest
mani
research
stimul
toward
coronaviru
perlman
morpholog
coronaviru
includ
spheric
pleomorph
shape
diamet
nm
master
genom
coronaviru
consist
open
read
frame
orf
orf
encompass
twothird
viral
genom
encod
nonstructur
polyprotein
four
orf
downstream
side
encod
structur
protein
envelop
protein
e
spike
protein
nucleocapsid
protein
n
membran
protein
coronavirus
hemagglutininesteras
gene
present
region
orf
marra
et
al
rota
et
al
snijder
et
al
structur
protein
fold
enter
endoplasm
reticulum
er
transport
ergolgi
transit
slot
master
replic
coronaviru
substanti
amount
structur
protein
synthes
order
assembl
progeni
virion
fung
liu
occupi
rna
genom
encod
structur
protein
protein
protein
n
protein
snijder
et
al
genom
size
first
import
merscov
strain
identifi
nucleotid
nt
long
includ
utr
strain
show
genom
structur
ornais
typic
betacoronaviru
untransl
two
main
polyprotein
cleav
nonstructur
protein
nsp
proteas
papainlik
proteas
plpro
proteas
cleav
along
orf
encod
nsp
essenti
activ
rna
depend
rna
polymeras
helicas
exoribonucleas
endoribonucleas
methyltransferas
nsp
identifi
necessari
proofread
ubiquit
mutat
rna
viru
ziebuhr
et
al
snijder
et
al
gorbalenya
et
al
smith
et
al
raj
et
al
durai
et
al
studi
reveal
accessori
orf
protein
play
import
role
merscov
infect
pathogenesi
menacheri
et
al
studi
show
absenc
major
accessori
orf
delet
play
major
role
viral
replic
pathogenesi
attenu
mutant
found
respons
dysregul
host
respons
augment
interferon
ifn
pathway
activ
disrupt
cell
process
robust
inflamm
thu
disrupt
accessori
orf
probabl
provid
platform
attenu
futur
emerg
strain
merscov
accessori
orf
mutant
accessori
orf
function
target
therapeut
vaccin
treatment
respons
merscov
relat
group
corona
virus
menacheri
et
al
graphic
represent
genom
organ
merscov
illustr
figur
coronavirus
demonstr
establish
doubl
membran
vesicl
dmv
infect
cell
base
immunehistochemistri
electron
microscop
studi
coronaviru
replicas
protein
coloc
dmv
assum
site
replicationtranscript
complex
fung
liu
interest
fact
coronavirus
display
recombin
high
rate
mutat
propens
cross
speci
one
event
report
epidem
transmiss
sarscov
occur
chines
horsesho
bat
human
popul
perlman
netland
merscov
capabl
adjust
new
environ
acquir
variou
virul
factor
enhanc
abil
transfer
factor
humantohuman
due
continu
outbreak
zumla
et
al
phylogenet
analysi
reveal
human
camel
merscov
identifi
homolog
addit
hedgehog
bat
merscov
demonstr
paraphylet
group
human
camel
merscov
clade
zhang
et
al
kim
report
occurr
mutant
strain
merscov
toward
human
receptor
south
korean
outbreak
furthermor
isol
new
viral
genom
possess
point
mutat
receptorbind
domain
rbd
protein
kim
protein
suggest
essenti
host
tropism
interact
host
receptor
van
doremalen
et
al
wang
et
al
entri
merscov
host
facilit
typei
transmembran
glycoprotein
known
protein
xia
et
al
rbd
merscov
consist
subunit
rang
amino
acid
group
extern
sub
domain
core
domain
shown
figur
receptorbind
motif
rbd
situat
extern
sub
domain
core
sub
domain
consist
antiparallel
fivestrand
six
helic
center
two
small
make
globular
fold
core
domain
structur
balanc
three
disulfid
linkag
merscov
rbd
extern
sub
domain
contain
along
figur
graphic
represent
structur
merscov
schemat
represent
show
structur
middl
east
respiratori
syndrom
coronaviru
contain
rna
enclos
nucleocapsid
within
envelop
embed
spike
protein
glycoprotein
membran
protein
van
den
brand
et
al
b
genom
organ
mer
cov
genom
organ
merscov
display
viral
gene
e
n
genom
encod
five
uniqu
accessori
protein
four
major
structur
protein
illustr
genom
scheme
gao
et
al
c
experiment
structur
merscov
complex
human
pdb
id
extracellular
rbd
domain
compris
nand
ctermin
ntermin
domain
ctermin
hydrolas
domain
genom
organ
receptor
bind
domain
rbd
illustr
subdomain
one
small
three
larg
strand
organ
antiparallel
manner
rbd
core
attach
region
special
interven
loop
bind
core
subdomain
clamp
lower
upper
region
connect
loop
two
small
helic
locat
inner
region
sheet
fourth
disulfid
linkag
stabil
among
residu
start
link
three
helic
center
three
chain
near
core
promot
releas
viral
particl
cytoplasm
promot
progress
infect
durai
et
al
middl
east
respiratori
syndrom
coronaviru
also
enter
cell
auxiliari
pathway
cell
surfac
via
transmembran
proteas
bind
merscov
host
cell
replic
viru
shown
figur
host
proteas
cleav
coronaviru
protein
two
function
domain
distinct
ntermin
region
denot
subunit
compris
rbd
ctermin
portion
subunit
compris
fusion
peptid
two
heptad
repeat
transmembran
tm
domain
weiss
navasmartin
membran
fusion
concili
main
conform
rearrang
expos
fusion
peptid
result
develop
sixhelix
bundl
core
consist
triplestrand
coil
like
structur
construct
three
spike
subunit
form
trimer
element
found
pack
within
groov
coil
coil
antiparallel
direct
owe
central
role
membran
fusion
report
variou
antivir
peptid
interfer
format
forni
et
al
clinic
present
merscov
compass
sever
respiratori
diseas
subclin
infect
hui
et
al
infect
patient
often
indic
presenc
hemoptysi
sore
throat
fever
cough
short
breath
gastrointestin
symptom
diarrhea
vomit
albarrak
et
al
assiri
et
al
b
gueri
et
al
health
protect
agenc
omrani
et
al
low
rang
lower
pulmonari
infiltr
associ
viral
pneumonia
observ
radiograph
patient
infect
merscov
memish
et
al
wang
observ
greater
initi
report
case
merscov
infect
patient
experienc
sever
diseas
demand
intens
care
treatment
like
extracorpor
membran
oxygen
mechan
ventil
hematolog
aberr
delin
clinic
case
neutrophilia
lymphopenia
thrombocytopenia
lymphocytosi
condit
kidney
failur
necessit
renal
replac
therapi
consider
number
merscov
case
sever
studi
detect
merscov
antigen
particl
renal
tissu
vivo
direct
indic
viru
replic
renal
tissu
long
term
acut
infect
alsaad
et
al
figur
life
cycl
merscov
display
fusion
plasma
membran
fusion
protein
plasma
membran
host
cell
format
doubl
membran
vesicl
host
cell
eventu
releas
rna
enclos
nucleocapsid
follow
genom
transcript
viral
rna
undergo
replic
transcript
follow
rna
synthesi
translat
endoplasm
reticulum
aid
assembl
packag
viru
particl
form
complet
doubl
membran
vesicl
lastli
exocytosi
merscov
releas
host
cell
du
et
al
frontier
microbiolog
wwwfrontiersinorg
first
evid
humantohuman
transmiss
merscov
report
case
unit
kingdom
adult
male
travel
saudi
arabia
transfer
infecti
viru
two
famili
member
perlman
netland
suggest
merscov
infect
due
introduct
viru
human
close
contact
camel
one
risk
factor
transmiss
mer
report
world
health
organ
world
health
organ
transmiss
merscov
determin
spasmod
often
healthcar
associ
intrafamili
requir
prolong
close
contact
memish
et
al
memish
et
al
b
puzelli
et
al
drosten
et
al
domest
studi
conduct
merscov
infect
patient
contact
posit
index
patient
antibodi
posit
rna
suggest
frequenc
transmiss
even
outbreak
approxim
sever
studi
suggest
viru
selfsustain
local
epidem
merscov
readili
transmit
one
human
report
major
human
relat
case
bauch
orabi
breban
et
al
cauchemez
et
al
chowel
nishiura
mode
transmiss
viru
illustr
figur
serolog
analysi
extens
investig
potenti
expos
patient
suggest
secondari
infect
world
health
organ
minimum
case
asymptomat
merscov
infect
report
health
care
person
function
subclin
case
transfer
infect
found
uncertain
de
sousa
et
al
intens
studi
coronaviru
research
past
year
limit
report
avail
pathogenesi
merscov
recent
postmortem
histopatholog
studi
reveal
local
viral
particl
pulmonari
extra
pulmonari
tissu
male
patient
cell
lymphoma
acquir
merscov
infect
ng
et
al
alsaad
et
al
histopatholog
analysi
biopsi
collect
lung
brain
liver
heart
kidney
skelet
muscl
demonstr
pulmonari
diffus
alveolar
damag
necrot
pneumonia
acut
kidney
injuri
portal
lobular
hepat
myositi
muscl
atroph
chang
viral
particl
found
local
pulmonari
macrophag
pneumocyt
renal
proxim
figur
transmiss
merscov
symptom
possess
infect
human
figur
show
path
viru
transmit
infect
camel
human
camel
variou
anim
kandeil
et
al
viru
transmit
human
popul
via
human
human
transmiss
shehata
et
al
tubular
epitheli
cell
macrophag
infiltr
skelet
muscl
alsaad
et
al
studi
suggest
pathogenesi
merscov
human
anim
mainli
due
three
mechan
dipeptidyl
mediat
mechan
papain
like
proteas
plpro
mediat
mechan
accessori
protein
like
membran
protein
mediat
mechan
henc
protein
probabl
consid
one
potenti
therapeut
target
merscov
infect
durai
et
al
molecular
mechan
exhibit
variou
mode
pathogenesi
illustr
figur
typeii
transmembran
glycoprotein
consist
approxim
amino
acid
function
major
receptor
merscov
three
dimension
structur
analysi
reveal
receptor
domain
domain
eight
blade
help
bind
receptor
bind
domain
merscov
raj
et
al
crystal
structur
illustr
figur
bind
protein
adenosin
deaminas
consid
one
major
inhibitor
protein
merscov
drosten
number
cell
line
humanderiv
hfl
hek
cell
line
suscept
merscov
report
chan
et
al
shirato
et
al
chu
et
al
two
protein
ectodomain
divid
fusioncatalyz
domain
fd
rbd
rbd
bind
fd
expos
unfold
cellular
viral
membran
join
togeth
refold
unfold
fd
requir
cleavag
protein
host
proteas
variou
proteolyt
cleavag
site
fd
rbd
cleavag
site
essenti
infect
cell
merscov
park
et
al
reveal
upon
infect
monocyt
chemo
attract
induc
suppress
prolifer
human
myeloid
progenitor
cell
zhou
et
al
merscov
infect
tcell
human
lymphoid
organ
caus
peripher
blood
induc
apoptosi
intrins
extrins
pathway
figur
molecular
mechan
pathogenesi
merscov
human
anim
pathogenesi
mechan
mainli
occur
papian
like
proteas
plpro
accessori
protein
membran
protein
durai
et
al
chu
et
al
studi
conduct
alqahtani
et
al
suggest
inhibit
mitig
induct
transcript
repressor
irakm
neg
regul
tlr
signal
indic
immunosuppress
action
glycoprotein
regul
upon
entri
cell
two
orf
end
viral
genom
translat
two
polyprotein
process
two
viral
proteas
plpro
proteinas
form
nonstructur
protein
necessari
membraneassoci
replic
complex
plpro
locat
nonstructur
protein
plpro
found
multifunct
enzym
deisgyl
remov
conjug
host
cell
factor
deubiquitin
cleavag
ubiquitin
host
cell
factor
properti
addit
proteas
activ
mani
coronavirus
clasman
et
al
result
host
antivir
immun
respons
antagon
promot
viral
replic
plpro
inhibit
mitochondri
antivir
signal
protein
induc
report
activ
reduc
induc
report
activ
henc
merscov
plpro
consid
import
antivir
target
mielech
et
al
harrigan
et
al
coronaviru
genom
encod
two
ubiquitinlik
domain
consid
import
compon
influenc
plpro
activ
clasman
et
al
report
plpro
show
deisgyl
deubiquitin
proteas
activ
absenc
domain
variat
process
inhibit
substrat
specif
catalyt
effici
thermal
stabil
clasman
et
al
viral
genom
recogn
melanoma
differentiationassoci
retino
acid
induc
endosom
tolllik
receptor
pathogenassoci
molecular
pattern
recognit
result
format
interferon
evas
mechan
viru
synthes
protein
hinder
product
pathway
zinzula
tramontano
absenc
merscov
use
protein
contain
rnabind
motif
bind
rabouw
et
al
direct
bind
motif
mask
dsrna
merscov
possess
fold
loop
helix
bind
minor
groov
dsrna
mutat
studi
reveal
complex
stabil
amino
acid
batool
et
al
studi
carri
canton
et
al
suggest
remain
cytoplasm
merscov
infect
cell
found
attach
nucleu
absenc
express
proinflammatori
cytokin
observ
transloc
nucleu
also
observ
case
mutant
devoid
nuclear
local
signal
indic
nuclear
local
signal
mediat
process
essenti
express
canton
et
al
compon
viral
envelop
protein
involv
variou
function
viral
assembl
along
protein
e
n
e
protein
interact
n
protein
ergolgi
complex
interact
hinder
fusion
viral
cellular
membran
mustafa
et
al
observ
express
protein
merscov
might
suppress
typei
ifn
express
respons
poli
c
induct
sendai
viru
infect
reaction
detect
specif
activ
ifn
regulatori
factor
howev
activ
nuclear
interact
merscov
protein
associ
disrupt
lead
reduc
activ
lui
et
al
middl
east
respiratori
syndrom
coronaviru
readili
infect
human
respiratori
epitheli
cell
macrophag
tcell
dendrit
cell
influenc
product
induct
proinflammatori
cytokin
chemokin
zhou
et
al
studi
ex
vivo
human
lung
tissu
respiratori
epitheli
cell
line
show
induct
antivir
interferon
follow
merscov
infect
stimul
epitheli
cell
found
limit
studi
menacheri
et
al
describ
cell
infect
merscov
demonstr
distinctli
alter
chromatin
structur
repress
histon
marker
could
limit
transcript
factor
bind
promot
region
interferonstimul
gene
chang
dna
methyl
found
one
reason
regul
antigenpres
gene
infect
menacheri
et
al
merscov
protein
plpro
found
suppress
induct
interferon
yang
et
al
mielech
et
al
canton
et
al
induct
proinflammatori
cytokin
respons
cell
found
limit
delay
induct
proinflammatori
cytokineschemokin
observ
upon
viral
infect
lau
et
al
canton
et
al
middl
east
respiratori
syndrom
coronaviru
could
infect
replic
human
monocytederiv
macrophag
immatur
monocytederiv
dendrit
cell
fail
perform
similar
function
matur
monocytederiv
dendrit
cell
indic
matur
restrict
viral
replic
immatur
dendrit
cell
unabl
stimul
tcell
even
antigen
uptak
delay
activ
tcell
permit
viral
replic
cong
et
al
infect
human
macrophag
induc
express
proinflammatori
cytokineschemokin
zhou
et
al
cong
et
al
infect
dendrit
cell
induc
express
howev
show
low
express
express
zhou
et
al
tcell
direct
infect
site
typei
ifn
stimul
secret
due
uncontrol
strong
express
express
inhibit
restrict
activ
thelper
cell
ad
effect
downregul
antigenpresent
pathway
activ
cell
inhibit
henc
sequest
cell
fail
target
viru
previou
studi
reveal
serum
sampl
bronchoalveolar
lavag
analyz
two
patient
observ
patient
low
level
secret
fail
surviv
patient
display
high
level
secret
typei
ifn
surviv
faur
et
al
anim
model
one
vital
compon
translat
find
drug
discoveri
process
bench
bedsid
anim
model
indispens
deeper
understand
diseas
safe
protect
vaccin
develop
process
lorenzen
et
al
main
criteria
valid
anim
model
preclin
studi
face
valid
predict
valid
target
valid
face
valid
mean
proper
similar
anim
model
human
diseas
term
biolog
symptom
diseas
howev
assess
face
valid
tediou
task
due
lack
understand
core
biolog
diseas
symptom
predict
valid
mean
display
clinic
intervent
exhibit
similar
effect
anim
model
also
difficult
achiev
due
incomplet
correl
anim
model
mechan
human
diseas
incap
standard
drug
activ
mani
anim
model
target
valid
anoth
essenti
compon
valid
anim
model
target
studi
must
analog
function
diseas
model
clinic
condit
denay
et
al
ideal
anim
model
one
immunocompet
anim
receiv
challeng
viru
realist
dose
suitabl
inocul
rout
abl
replic
characterist
human
diseas
close
possibl
doremalen
munster
ferret
hamster
mice
small
laboratori
anim
ideal
anim
model
merscov
owe
variat
receptor
rhesu
macaqu
common
marmoset
first
nonhuman
primat
speci
np
use
anim
model
merscov
glycosyl
mous
prevent
bind
protein
merscov
henc
transgen
human
mice
develop
anim
model
peck
et
al
major
advantag
limit
merscov
anim
model
list
tabl
studi
suggest
glycosyl
certain
amino
acid
prevent
bind
mous
protein
merscov
doremalen
munster
first
transgen
merscov
mous
model
establish
agraw
et
al
mice
express
develop
sever
respiratori
merscov
infect
transgen
mice
infect
intranas
dose
merscov
develop
pneumonia
weight
loss
acut
pulmonari
viral
infect
ruffl
fur
squint
death
within
day
transgen
mous
model
develop
zhao
et
al
show
limit
util
pathogen
studi
due
system
dissemin
develop
sever
neurolog
diseas
lung
infect
model
lack
mortal
weight
loss
howev
develop
lung
patholog
respons
tcid
merscov
recent
studi
suggest
transgen
mice
model
develop
fulllength
gene
replac
infect
replic
merscov
observ
lung
howev
dissemin
slow
impact
organ
post
inject
dose
rang
pfu
patholog
infect
mice
show
pneumonialik
symptom
gene
edit
tool
use
produc
mice
suscept
merscov
infect
modifi
genom
sequenc
posit
homolog
sequenc
certain
mice
model
characterist
symptom
pulmonari
hemorrhag
low
surviv
decreas
pulmonari
function
weight
loss
observ
mous
model
demonstr
sever
respiratori
infect
observ
human
cockrel
et
al
upon
infect
merscov
rhesu
macaqu
marmoset
develop
moder
respiratori
diseas
compar
mild
human
merscov
infect
observ
human
case
also
show
complet
blood
count
abnorm
rhesu
macaqu
marmoset
model
found
suitabl
pathogen
studi
mild
infect
model
use
efficaci
test
prophylact
therapeut
countermeasur
basel
et
al
yu
et
al
report
old
rhesu
macaqu
common
marmoset
intratrach
inject
hcovemc
hematoxylin
eosin
stain
tissu
infect
model
demonstr
lesion
primarili
lung
variou
degre
inflamm
hemorrhag
pulmonari
oedema
interstiti
pneumonia
eosinophil
infiltr
necrosi
bronchial
epitheli
cell
pneumocyt
lung
infect
marmoset
demonstr
widespread
pulmonari
oedema
hemorrhag
oedemat
alveolar
caviti
show
fibrin
exud
neutrophil
infiltr
case
wide
express
alveolar
macrophag
typei
ii
pneumocyt
also
activ
involv
patholog
chang
result
viral
infect
observ
organ
infect
anim
yu
et
al
case
merscov
caus
sever
infect
lower
respiratori
tract
human
nasal
swab
collect
infect
rabbit
demonstr
presenc
merscov
gener
develop
respiratori
diseas
asymptomat
mild
human
infect
sometim
observ
immunecompet
patient
recent
houser
et
al
reveal
infect
new
zealand
rabbit
develop
asymptomat
pulmonari
infect
high
level
viral
antigen
rna
multipl
lung
lobe
show
perivascular
inflamm
antibodi
develop
rabbit
lack
neutral
activ
result
anim
suscept
reinfect
fact
enhanc
pulmonari
inflamm
observ
reinfect
howev
reinfect
elicit
neutral
antibodi
nab
henc
suggest
upon
reinfect
might
greater
risk
sever
lung
diseas
develop
neutral
antibodi
respons
whose
neutral
antibodi
titer
decreas
initi
infect
houser
et
al
clinic
sign
lesion
along
occurr
merscov
rna
antigen
observ
merscov
infect
anim
model
shown
tabl
primari
diagnosi
merscov
infect
perform
molecular
techniqu
realtim
revers
transcriptas
pcr
rtpcr
corman
et
al
revers
transcriptionloopmedi
isotherm
amplif
rtrtpa
shirato
et
al
revers
transcriptionrecombinas
polymeras
amplif
rtlamp
abd
et
al
numer
serolog
assay
use
detect
merscov
close
relat
virus
seroposit
camel
test
protein
microarray
like
indirect
enzymelink
immunosorb
assay
elisa
recombin
spike
immunofluoresc
assay
spike
pseudoparticl
neutral
microneutr
assay
buchholz
et
al
perera
et
al
howev
none
serolog
assay
show
evid
precis
occurr
merscov
camel
song
et
al
recent
studi
report
rapid
specif
assay
detect
merscov
nucleic
acid
visual
techniqu
combin
revers
transcript
loopmedi
isotherm
amplif
techniqu
vertic
flow
visual
strip
rtlampvf
detect
n
gene
merscov
huang
et
al
studi
suggest
comparison
realtim
rtpcr
rrtpcr
method
recommend
world
health
organ
rtlampvf
assay
easi
perform
rapid
detect
merscov
within
min
achiev
approach
huang
et
al
assay
develop
base
detect
n
protein
merscov
song
et
al
np
protein
prefer
better
target
protein
type
assay
firstli
antigen
bind
gold
label
monoclon
antibodi
lead
format
antigenantibodi
complex
complex
pass
nitrocellulos
membran
bind
monoclon
antibodi
test
region
form
band
could
conveni
analyz
tang
current
multipl
purifi
monoclon
antibodi
avail
clinic
preclin
studi
develop
antimicrobi
rockx
et
al
studi
suggest
two
human
antibodi
known
bind
merscov
rbd
prevent
interact
cellular
receptor
protein
effect
neutral
merscov
infect
pascal
et
al
antibodi
show
bind
protein
thu
employ
effect
combin
inhibit
merscov
aderem
et
al
cointeract
merscov
rbd
suggest
antibodi
bind
discret
epitop
bind
region
merscov
protein
conserv
natur
evolut
viru
two
antibodi
block
entri
viru
suscept
cell
line
neutral
infect
pascal
et
al
diagnost
relev
variat
neutral
activ
detect
sever
isol
merscov
order
detect
serolog
respons
specif
type
singl
merscov
serotyp
specif
protein
base
seroassay
essenti
perform
muth
et
al
develop
potenti
serolog
assay
demand
well
delin
human
anim
sera
antibodi
specif
merscov
previou
studi
reveal
cellular
humor
respons
requir
complet
protect
merscov
infect
faur
et
al
park
et
al
corman
et
al
nab
tcell
respons
main
agent
provid
protect
immun
coronavirus
studi
zhao
et
al
report
merscov
clear
mice
lack
bcell
defici
tcell
fail
perform
similar
function
sinc
virusspecif
humor
respons
decreas
time
develop
vaccin
could
induc
longliv
memori
tcell
respons
consid
benefici
howev
vaccin
compound
abl
induc
bcell
respons
requir
immun
protect
okba
et
al
merscov
vaccin
candid
still
develop
dna
base
protein
base
live
attenu
vectoredviru
base
vaccin
arabi
et
al
four
structur
protein
sixteen
non
structur
protein
encod
viral
genom
protein
show
highest
immunogen
induc
tcell
respons
merscov
nab
target
rbd
protein
variat
amino
acid
sequenc
protein
detect
amongst
merscov
limit
thu
design
vaccin
one
strain
like
protect
circul
strain
okba
et
al
protein
locat
outsid
rbd
probabl
consid
potenti
drug
target
develop
therapeut
strategi
merscov
rbdspecif
mab
consid
display
greater
neutral
activ
target
region
outsid
rbd
du
et
al
therapeut
agent
capabl
block
interact
merscov
rbd
therefor
inhibit
merscov
infect
antibodi
prevent
entri
merscov
suscept
cell
obstruct
viru
infect
ohnuma
et
al
addit
protein
adenosin
deaminas
ada
compet
bind
merscov
rbd
specif
crucial
residu
defin
role
natur
occur
antagonist
raj
et
al
recent
studi
reveal
dna
vaccin
safest
vaccin
immunecompromis
patient
possess
compar
greater
amount
dna
eg
mg
thu
requir
multipl
inocul
induc
potent
immun
respons
rhesu
macaqu
mice
wirblich
et
al
chi
et
al
develop
dna
vaccin
encod
first
amino
acid
protein
merscov
induc
cell
mediat
antigenspecif
humor
immun
respons
mice
post
three
immun
observ
high
titer
nab
produc
without
adjuv
prophylact
dnaplasmid
vaccin
known
encod
protein
first
merscov
vaccin
consid
human
trial
develop
geneon
life
inc
enlist
ongo
list
vaccin
rabaan
et
al
world
health
organ
vaccin
imit
natur
infect
recombin
viral
vector
liveattenu
viru
present
antigen
natur
way
stimul
activ
humor
cellmedi
immun
nativ
protein
conform
live
attenu
virus
immunogen
platform
avail
exhibit
capabl
present
numer
antigen
across
viral
life
cycl
nativ
conform
henderson
moss
agraw
et
al
vaccin
mice
inactiv
merscov
vaccin
demonstr
hypersensit
risk
factor
merscov
infect
although
extens
research
last
year
limit
antimerscov
therapeut
approv
human
use
origin
convent
ifa
employ
human
serosurvey
reli
merscov
infect
cell
cultur
cell
cultur
primari
antigen
sourc
detect
presenc
human
antimerscov
nab
igm
igg
human
sampl
corman
et
al
report
human
monoclon
antibodi
demonstr
signific
neutral
properti
merscov
vitro
condit
houser
et
al
recent
studi
reveal
antivir
agent
development
stage
report
antivir
drug
chlorpromazin
demonstr
strong
antimerscov
potenti
howev
high
cytotox
drug
limit
potenti
window
drug
util
similarli
anoth
drug
toremifen
show
moder
activ
test
antigen
present
cell
howev
high
cytotox
drug
also
narrow
applic
therapeut
remedi
merscov
cong
et
al
studi
suggest
nucleosid
analog
known
remdesivir
show
potenti
antivir
activ
human
zoonot
cov
vitro
drug
inhibit
merscov
effect
concentr
valu
agostini
et
al
conserv
natur
n
protein
use
develop
vaccin
induc
adapt
immun
respons
protein
studi
zhao
et
al
report
vaccin
candid
induc
airway
memori
cell
respons
nspecif
epitop
merscov
anoth
studi
suggest
vaccin
recombin
ntermin
domain
rntd
trigger
greater
tcell
respons
mice
vaccin
rrbd
neutral
activ
also
observ
sera
jiam
et
al
recent
studi
reveal
combin
fusion
inhibitori
peptid
target
protein
domain
merscov
neutral
antibodi
specif
protein
rbd
show
synergist
therapeut
activ
merscov
wang
et
al
research
develop
novel
neutral
nanobodi
nb
specif
bind
rbd
merscov
protein
nb
found
interact
conserv
domain
merscov
rbd
high
affin
block
bind
rbd
receptor
merscov
immunodomin
epitop
within
protein
structur
may
contribut
neg
neutral
activ
vaccin
exampl
short
region
rbd
abl
induc
higher
titer
igg
compar
longer
region
et
al
neg
effect
epitop
surmount
immunofocus
map
neutral
rbd
fragment
elimin
unnecessari
fragment
help
focus
immun
respons
import
epitop
et
al
pallesen
et
al
suggest
structurebas
design
protein
improv
immunogen
high
titer
nab
observ
merscov
major
categori
vaccin
develop
test
variou
anim
model
shown
tabl
technolog
progress
reflect
upon
seri
genom
wide
molecular
screen
platform
comput
biolog
approach
provid
novel
insight
prompt
respons
emerg
viral
diseas
prototyp
approach
includ
vivo
anim
model
tissu
cultur
model
human
challeng
model
vaccin
studi
model
system
anxiou
challeng
prefer
yield
spectra
sever
diseas
like
lethal
versu
subleth
order
increas
diverg
downstream
data
mine
model
mcdermott
et
al
drosten
et
al
law
et
al
divers
comput
methodolog
network
approach
use
detect
regulatori
network
variou
viral
system
de
novo
studi
hou
zhao
mitchel
et
al
recent
studi
shown
peptid
util
highli
potent
signal
transduct
agent
variou
viral
infect
suggest
antimicrobi
peptid
amp
use
potenti
therapeut
option
merscov
infect
mustafa
et
al
comput
biolog
approach
combin
virolog
employ
design
novel
peptid
base
therapeut
variou
strain
merscov
high
efficaci
recent
studi
suggest
repurpos
exist
clinic
approv
antivir
peptid
use
promis
lead
molecul
develop
novel
antimerscov
agent
mustafa
et
al
rbd
protein
base
vector
vaccin
consid
one
effici
target
design
merscov
vaccin
compris
multipl
neutral
epitop
offer
higher
potenti
prompt
nab
viru
vast
develop
comput
biolog
led
new
line
immunoinformat
databas
tool
oper
way
vaccin
develop
terri
et
al
screen
domin
immunogen
base
avail
genom
sequenc
data
crucial
design
novel
vaccin
assist
immunoinformat
firba
et
al
epitop
direct
lead
design
one
critic
step
involv
lead
identif
immunoinformat
approach
mhci
restrain
cytotox
tlymphocyt
ctl
identif
provid
profound
insight
design
novel
antivir
agent
terri
et
al
conclus
merscov
infect
continu
fatal
diseas
emerg
one
epidem
concern
irrespect
variou
studi
conduct
determin
distribut
exact
intermedi
remain
unidentifi
variou
anim
model
avail
provid
profound
insight
understand
transmiss
pathogenec
viru
human
common
pathogenesi
mechan
viru
plpro
accessori
protein
like
membran
protein
provid
signific
insight
screen
novel
drug
target
vaccin
develop
detail
understand
bind
mechan
variou
inhibitor
toward
structur
nonstructur
accessori
protein
viru
probabl
provid
profound
insight
lead
develop
integr
genom
analysi
proteom
studi
immunoinformat
system
biolog
approach
variou
anim
model
made
recognit
new
target
lead
molecul
much
easier
approach
avail
earlier
time
consid
merscov
infect
one
great
public
threat
high
demand
undertak
coronaviru
research
deeper
molecular
level
understand
mechan
viral
infect
develop
advanc
rapid
detect
method
futurist
therapeut
strategi
combat
merscov
infect
ss
sc
sp
sk
vs
collect
data
prepar
complet
manuscript
ss
review
revis
edit
manuscript
